The human immunodeficiency virus-1 envelope protein gp120 binds through its V3 sequence to the glycine site of N-methyl-D-aspartate receptors mediating noradrenaline release in the hippocampus

Neuroscience

Volumn 87, Issue 1, 1998, Pages 147-157

  Pattarini, R ^a   Pittaluga, A ^a   Raiteri, M ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

AIDS dementia complex; gp120; HIV 1 proteins; NMDA receptors; Noradrenaline release; V3 loop

Indexed keywords

ENVELOPE PROTEIN; GLYCOPROTEIN GP 120; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BINDING AFFINITY; BINDING SITE; HIPPOCAMPUS; HUMAN IMMUNODEFICIENCY VIRUS 1; NORADRENALIN RELEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; RECEPTOR AFFINITY; RECEPTOR BINDING; SYNAPTOSOME;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD4; GALACTOSYLCERAMIDES; HIPPOCAMPUS; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP160; HIV ENVELOPE PROTEIN GP41; HIV-1; MALE; MOLECULAR SEQUENCE DATA; NEURONS; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLYCINE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0032581185     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00125-0     Document Type: Article

References (65)

1. Bagetta G., Corasaniti M. T., Costa N., Berliocchi L., Finazzi-Agrò A., Nisticò G. The human immunodeficiency virus type 1 (HIV-1) glycoprotein gp120 reduces the expression of neuronal nitric oxide synthase in the hippocampus but not in the cerebral cortex and medial septal nucleus of rat. Neurosci. Lett. 224:1997;75-78.
2. Barbour B., Szatkowski M., Ingledew N., Attwell D. Arachidonic acid induces a prolonged inhibition of glutamate uptake into glial cells. Nature. 342:1989;918-920.
3. Barks J. D. E., Liu X.-H., Sun R., Silverstein F. S. gp120, a human immunodeficiency virus-1 coat protein, augments excitotoxic hippocampal injury in perinatal rats. Neuroscience. 76:1997;397-409.
4. Bhat S., Spitalnik S. L., Gonzalez-Scarano F., Silberberg D. H. Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope gp120. Proc. natn. Acad. Sci. U.S.A. 88:1991;7131-7134.
5. Bradford M. M. Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analyt. Biochem. 72:1976;248-254.
6. Brenneman D. E., McCune S. K., Gozes I. Acquired immune deficiency syndrome and the developing nervous system. Int. Rev. Neurobiol. 32:1990;305-353.
7. Brenneman D. E., Westbrook G. L., Fitzgerald S. P., Ennist D. L., Elkins K. L., Ruff M. R., Pert C. B. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature. 335:1988;639-642.
8. Cahill L., Prins B., Weber M., McGaugh J. L. Beta-adrenergic activation and memory for emotional events. Nature. 371:1994;702-704.
9. Chéramy A., Godeheu G., L'Hirondel M., Glowinski J. Cooperative contribution of cholinergic and NMDA receptors in the presynaptic control of dopamine release from synaptosomes of the rat striatum. J. Pharmac. exp. Ther. 276:1996;616-625.
10. i increases in a glial cell subpopulation. Eur. J. Neurosci. 5:1991;1711-1718.
11. i responses not only in type-2 but also type-1 astrocytes and oligodendrocytes of the rat cerebellum. Eur. J. Neurosci. 7:1995;1333-1341.
12. Collingridge G. L., Bliss T. V. P. NMDA receptors: their role in long-term potentiation. Trends Neurosci. 10:1987;288-293.
13. Cook D. G., Fantini J., Spitalnik S. L., Gonzalez-Scarano F. Binding of human immunodeficiency virus type I (HIV-1) gp120 to galactosylceramide (GalCer): relationship to the V3 loop. Virology. 201:1994;206-214.
14. Desce J. M., Godeheu G., Galli T., Artaud F., Chéramy A., Glowinski J. L-Glutamate-evoked release of dopamine from synaptosomes of the rat striatum: involvement of AMPA and N-methyl-D-aspartate receptors. Neuroscience. 47:1992;333-339.
15. Dunkley P. R., Health J. W., Harrison S. M., Jarvie P. E., Glefield P. J., Rostas J. A. P. A rapid Percoll gradient procedure for isolation of synaptosomes directly from S1 fraction: homogeneity and morphology of subcellular fractions. Brain Res. 441:1988;59-71.
16. Everall I. P., Luthert P. J., Lantos P. L. Neuronal loss in the frontal cortex in HIV infection. Lancet. 337:1991;1119-1121.
17. 3H]Glycine uptake in rat hippocampus: kinetic analysis and autoradiographic localization. Brain Res. 572:1992;154-163.
18. Finberg R. W., Diamond D. C., Mitchell D. B., Rosenstein Y., Soman G., Norman T. C., Schreiber S. L., Burakoff S. J. Prevention of HIV-1 infection and preservation of CD4 function by the binding of CPFs to gp120. Science. 249:1990;287-291.
19. Fink K., Bönisch H., Göthert M. Presynaptic NMDA receptors stimulate noradrenaline release in the cerebral cortex. Eur. J. Pharmac. 185:1990;115-117.
20. Fink K., Schultheiss R., Göthert M. Stimulation of noradrenaline release in human cerebral cortex mediated by N-methyl-D-aspartate (NMDA) and non-NMDA receptors. Br. J. Pharmac. 106:1992;67-72.
21. Fontana G., Valenti L., Raiteri M. Gp120 can revert antagonism at the glycine site of NMDA receptors mediating GABA release from cultured hippocampal neurons. J. Neurosci. Res. 49:1997;732-738.
22. Funke I., Hahn A., Rieber E. P., Weiss E., Riethmüller G. The cellular receptor (CD4) of the human immunodeficiency virus is expressed on neurons and glial cells in human brain. J. exp. Med. 165:1987;1230-1235.
23. Giulian D., Wendt E., Vaca K., Noonan C. The envelope glycoprotein of HIV-1 stimulates monocyte release of neurotoxins. Proc. natn. Acad. Sci. U.S.A. 90:1993;2769-2773.
24. Giulian D., Yu J., Li X., Tom D., Li J., Wendt E., Lin S. N., Schwarcz R., Noonan C. Study of receptor-mediated neurotoxins released by HIV-1-infected mononuclear phagocytes found in human brain. J. Neurosci. 16:1996;3139-3153.
25. Glass J. D., Johnson R. T. Human immunodeficiency virus and the brain. A. Rev. Neurosci. 19:1996;1-26.
26. Glowa J. R., Panlilio L. V., Brenneman D. E., Gozes I., Fridkin M., Hill J. M. Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist. Brain Res. 570:1992;49-53.
27. Heyes M. P., Brew B. J., Martin A., Price R. W., Salazar A. M., Sidtis J. J., Yergey J. A., Mouradian M. M., Sadler A. R., Kelip J. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann. Neurol. 29:1991;202-229.
28. Hill J. M., Mervis R. F., Avidor R., Moody T. W., Brenneman D. E. HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates. Brain Res. 603:1993;222-233.
29. Ho D. D., Kaplan J. C., Rackauskas I. E., Gurney M. E. Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization. Science. 239:1988;1021-1023.
30. Johnson J. W., Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature. 325:1987;529-531.
31. Kemp J. A., Foster A. C., Leeson P. D., Priestley T., Tridgett R., Iversen L. L., Woodruff G. N. 7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex. Proc. natn. Acad. Sci. U.S.A. 85:1988;6547-6550.
32. Kleckner N. D., Dingledine R. Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. Science. 241:1988;835-837.
33. i homeostasis and induce neurotoxicity in human embryonic neurons. Eur. J. Neurosci. 7:1995;2285-2293.
34. La Rosa G. J., Davide J. P., Weinhold K., Waterbury J. A., Profy A. T., Lewis J. A., Langlois A. J., Dreesman G. R., Boswell R. N., Shadduck P., Holley L. H., Karplus M., Bolognesi D. P., Matthews T. J., Emini E. A., Putney S. D. Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science. 249:1990;932-935.
35. Lipton S. A. Requirement for macrophages in neuronal injury induced by HIV envelope protein gp120. NeuroReport. 3:1992;913-915.
36. 2+, N-methyl-D-aspartate receptors, and AIDS-related neuronal injury. Int. Rev. Neurobiol. 36:1994;1-27.
37. Lipton S. A., Sucher N. J., Kaiser P. K., Dreyer E. B. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron. 7:1991;111-118.
38. Masliah E., Achim C. L., Ge N., DeTeresa R., Terry R. D., Wiley C. A. Spectrum of human immunodeficiency virus-associated neocortical damage. Ann. Neurol. 32:1992;321-329.
39. McDougal J. S., Kennedy M. S., Sligh J. M., Cort S. P., Mawle A., Nicholson J. K. Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule. Science. 231:1986;382-385.
40. McGaugh J. Involvement of hormonal and neuromodulatory systems in the regulation of memory storage. A. Rev. Neurosci. 12:1989;255-287.
41. Meucci O., Miller R. J. gp120-induced neurotoxicity in hippocampal pyramidal neuron cultures: protective action of TGF-β1. J. Neurosci. 16:1996;4080-4088.
42. Moore J. P., Sattentau Q. J., Wyatt R., Sodroski J. Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies. J. Virol. 68:1994;469-484.
43. Müller W. E. G., Schröder H. C., Ushijima H., Dapper J., Bormann J. Gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by memantine. Eur. J. Pharmac. molec. Pharmac. Sect. 226:1992;209-214.
44. Navia B. A., Cho E. S., Petito C. K., Price R. W. The AIDS dementia complex. II. Neuropathology. Ann. Neurol. 19:1986;525-535.
45. Olpe H. R., Steimann M. W., Brugger F., Pozza M. F. Excitatory amino acid receptors in rat locus coeruleus. An extracellular in vitro study. Naunyn-Schmiedeberg's Arch. Pharmac. 339:1989;312-314.
46. Omri B., Crisanti P., Alliot F., Marty M. C., Rutin J., Levallois C., Privat A., Pessac B. CD4 expression in neurons of the central nervous system. Int. Immun. 6:1994;377-385.
47. Parmantier E., Monge M., Yagello M., Cabon F., Demerens C., Gluckman J. C., Zalc B. HIV-1 envelope glycoprotein gp120 does not bind to galactosylceramide-expressing rat oligodendrocytes. Virology. 206:1995;1084-1091.
48. Pert C. B., Smith C. C., Ruff M. R., Hill J. M. AIDS and its dementia as a neuropeptide disorder: role of VIP receptor blockade by human immunodeficiency virus envelope. Ann. Neurol., Suppl. 23:1988;S71-S73.
49. Pittaluga A., Pattarini R., Severi P., Raiteri M. Human brain N-methyl-D-aspartate receptors regulating noradrenaline release are positively modulated by HIV-1 coat protein gp120. AIDS. 10:1996;463-468.
50. Pittaluga A., Raiteri M. Release-enhancing glycine-dependent presynaptic NMDA receptors exist on noradrenergic terminals of hippocampus. Eur. J. Pharmac. 191:1990;231-234.
51. Pittaluga A., Raiteri M. N-Methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal noradrenaline release. I. Location on axon terminals and pharmacological characterization. J. Pharmac. exp. Ther. 260:1992;232-237.
52. Pittaluga A., Raiteri M. HIV-1 envelope protein gp120 potentiates NMDA-evoked noradrenaline release by a direct action at rat hippocampal and cortical noradrenergic nerve endings. Eur. J. Neurosci. 6:1994;1743-1749.
53. Raiteri M., Angelini F., Levi G. A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur. J. Pharmac. 25:1974;411-414.
54. Raiteri M., Bonanno G., Marchi M., Maura G. Is there a functional linkage between neurotransmitter uptake mechanisms and presynaptic receptors? J. Pharmac. exp. Ther. 231:1984;671-677.
55. Raiteri M., Maura G., Versace P. Functional evidence for two stereochemically different alpha-2 adrenoceptors regulating central norepinephrine and serotonin release. J. Pharmac. exp. Ther. 224:1983;679-684.
56. 3H]noradrenaline release is modulated by glycine. Eur. J. Pharmac. 156:1988;149-155.
57. 3H]dopamine release from rat striatum: an in vitro model for glutamate actions. J. Neurochem. 32:1979;1539-1545.
58. Rusche J. R., Javaherian K., McDanal C., Petro J., Lynn D. L., Grimaila R., Langlois A., Gallo R. C., Arthur L. O., Fischinger P. J., Bolognesi D. P., Putney S. D., Matthews T. J. Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proc. natn. Acad. Sci. U.S.A. 85:1988;3198-3202.
59. Sattentau Q. J., Weiss R. A. The CD4 antigen: physiological ligand and HIV receptor. Cell. 52:1988;631-633.
60. Savio T., Levi G. Neurotoxicity of HIV coat protein gp120, NMDA receptors, and protein kinase C: a study with rat cerebellar granule cell cultures. J. Neurosci. Res. 34:1993;265-272.
61. Sharpless N., Gilbert D., Vandercam B., Zhou J. M., Verdin E., Ronnet G., Friedman E., Dubois-Dalcq M. The restricted nature of HIV-1 tropism for cultured neural cells. Virology. 191:1992;813-825.
62. Starcich B. R., Hahn B. H., Shaw G. M., McNeely P. D., Modrow S., Wolf H., Parks E. S., Parks W. P., Josephs S. F., Gallo R. C., Wong-Staal F. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell. 45:1986;637-648.
63. Ushijima H., Kunisada T., Schröder H. C., Klöcking P., Müller W. E. G. HIV 1-gp120 and NMDA differentially induce protein kinase C translocation in rat primary neuronal cultures. J. Acq. Immun. Defic. Syndr. 6:1993;339-343.
64. Ushijima H., Nishio O., Klöcking R., Perovic S., Müller W. E. G. Exposure to gp120 of HIV-1 induces an increased release of arachidonic acid in rat primary neuronal cell culture followed by NMDA receptor-mediated neurotoxicity. Eur. J. Neurosci. 7:1995;1353-1359.
65. Volterra A., Trotti D., Cassutti P., Tromba C., Salvaggio A., Melcangi R. C., Racagni G. High sensitivity of glutamate uptake to extracellular free arachidonic acid levels in rat cortical synaptosomes and astrocytes. J. Neurochem. 59:1992;600-606.